Blood pressure drug may stop knee scarring after ACL repair
NCT ID NCT07135687
First seen Nov 01, 2025 · Last updated May 19, 2026 · Updated 22 times
Summary
This study tests whether losartan, a common blood pressure medicine that also has anti-scarring effects, can prevent abnormal scar tissue (arthrofibrosis) in the knee after ACL reconstruction. About 144 adults undergoing ACL repair will take losartan or a placebo. The main goal is to see if the drug helps maintain knee range of motion over 12 months.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ACL INJURY are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Rush University Medical Center
Chicago, Illinois, 60612, United States
Contact
Contact Email: •••••@•••••
Contact
Contact
Contact
Contact
Contact Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.